UNSPSC 85494710: Supplement superior vena cava with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement superior vena cava with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UV4KZ

UNSPSC 85494710 Supplement superior vena cava with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not align with actual state and local procurement activity represented in recent solicitations. The code nominally describes a clinical procedure involving vascular grafting, yet the five recent opportunities posted under this code span independent medical evaluation services, surgical benefit carve-outs, occupational health surveillance, youth detention healthcare, pharmacy benefit management, and temporary clinical staffing — none of which involve superior vena cava procedures or procurement of prosthetic tissue substitutes. The mismatch between the code's clinical-procedure name and the scope of work being solicited suggests a cataloging error in the posting systems rather than legitimate activity under this Commodity code.

No state and local procurement activity directly related to vena cava grafting procedures or nonautologous tissue substitutes appears in the recent opportunities block. The issuing bodies tagging opportunities to this code include the City of Phoenix Retirement Office, the City of Long Beach, the Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and the County of Santa Clara Health System — representing municipal, county, and state health and administrative functions — but their work is administrative healthcare contracting and staffing rather than clinical supply or implant procurement. Absent evidence of genuine procurement under the code's nominal scope, this Commodity code shows little relevant recent activity for vendors in medical device supply, surgical implants, or vascular-tissue-substitute distribution.